Given the decrease in IGF-1 can be ≥2 SD in some patients and thereby potentially clinically significant, we recommend interval monitoring of serum IGF-1 in patients with hypogonadism treated with clomiphene citrate. Here, IGF1 is linked to hypogonadism.